Software - Application
Build Your Comparison
Side-by-side financial analysisStock Comparison
CYN vs IROQ vs JPM vs BAC vs NECB vs KO
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Diversified
Banks - Diversified
Banks - Regional
Beverages - Non-Alcoholic
CYN vs IROQ vs JPM vs BAC vs NECB vs KO — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||||
|---|---|---|---|---|---|---|
| Industry | Software - Application | Banks - Regional | Banks - Diversified | Banks - Diversified | Banks - Regional | Beverages - Non-Alcoholic |
| Market Cap | $14M | $89M | $896.00B | $422.78B | $359M | $355.61B |
| Revenue (TTM) | $276K | $48M | $280.33B | $191.57B | $156M | $49.28B |
| Net Income (TTM) | $-26M | $5M | $57.05B | $30.51B | $44M | $13.70B |
| Gross Margin | 34.4% | 59.5% | 60.0% | 56.1% | 65.9% | 61.7% |
| Operating Margin | -99.2% | 14.9% | 25.9% | 19.7% | 39.8% | 29.3% |
| Forward P/E | — | 19.4x | 14.4x | 12.6x | 8.3x | 25.3x |
| Total Debt | $7M | $73M | $942.38B | $365.90B | $75M | $45.49B |
| Cash & Equiv. | $990K | $20M | $343.34B | $231.84B | $81M | $10.27B |
CYN vs IROQ vs JPM vs BAC vs NECB vs KO — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Oct 21 | Jun 26 | Return |
|---|---|---|---|
| Cyngn Inc. (CYN) | 100 | 0.0 | -100.0% |
| IF Bancorp, Inc. (IROQ) | 100 | 123.2 | +23.2% |
| JPMorgan Chase & Co. (JPM) | 100 | 188.8 | +88.8% |
| Bank of America Cor… (BAC) | 100 | 117.2 | +17.2% |
| Northeast Community… (NECB) | 100 | 237.0 | +137.0% |
| The Coca-Cola Compa… (KO) | 100 | 146.6 | +46.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CYN vs IROQ vs JPM vs BAC vs NECB vs KO
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Among these 6 stocks, CYN doesn't own a clear edge in any measured category.
IROQ is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 6.6%, EPS growth 140.4%
- 6.6% NII/revenue growth vs CYN's -40.5%
JPM doesn't hold a clear category lead here; it's more of a secondary option in this specific comparison.
BAC ranks third and is worth considering specifically for momentum.
- +28.1% vs CYN's -72.6%
NECB carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 2 yrs, beta 0.71, yield 3.8%
- 5.0% 10Y total return vs JPM's 465.8%
- Lower volatility, beta 0.71, Low D/E 21.4%, current ratio 0.06x
- PEG 0.25 vs KO's 2.26
KO is the clearest fit if your priority is efficiency.
- 13.1% ROA vs CYN's -48.1%, ROIC 15.8% vs -117.2%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 6.6% NII/revenue growth vs CYN's -40.5% | |
| Value | Lower P/E (8.3x vs 25.3x), PEG 0.25 vs 2.26 | |
| Quality / Margins | 28.4% margin vs CYN's -94.2% | |
| Stability / Safety | Beta 0.71 vs CYN's 2.18 | |
| Dividends | 3.8% yield, 2-year raise streak, vs KO's 2.5%, (1 stock pays no dividend) | |
| Momentum (1Y) | +28.1% vs CYN's -72.6% | |
| Efficiency (ROA) | 13.1% ROA vs CYN's -48.1%, ROIC 15.8% vs -117.2% |
CYN vs IROQ vs JPM vs BAC vs NECB vs KO — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
CYN vs IROQ vs JPM vs BAC vs NECB vs KO — Financial Metrics
Side-by-side numbers across 6 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NECB leads in 2 of 6 categories
KO leads 1 • CYN leads 0 • IROQ leads 0 • JPM leads 0 • BAC leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NECB leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 1014240.4x CYN's $276,397. NECB is the more profitable business, keeping 28.4% of every revenue dollar as net income compared to CYN's -94.2%. On growth, CYN holds the edge at +121.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||||
|---|---|---|---|---|---|---|
| RevenueTrailing 12 months | $276,397 | $48M | $280.3B | $191.6B | $156M | $49.3B |
| EBITDAEarnings before interest/tax | -$26M | $7M | $81.4B | $40.0B | $63M | $15.5B |
| Net IncomeAfter-tax profit | -$26M | $5M | $57.0B | $30.5B | $44M | $13.7B |
| Free Cash FlowCash after capex | -$27M | $6M | $100.9B | $12.6B | $51M | $12.6B |
| Gross MarginGross profit ÷ Revenue | +34.4% | +59.5% | +60.0% | +56.1% | +65.9% | +61.7% |
| Operating MarginEBIT ÷ Revenue | -99.2% | +14.9% | +25.9% | +19.7% | +39.8% | +29.3% |
| Net MarginNet income ÷ Revenue | -94.2% | +10.8% | +20.4% | +15.9% | +28.4% | +27.8% |
| FCF MarginFCF ÷ Revenue | -97.1% | +12.4% | +36.0% | +6.6% | +32.5% | +25.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | +121.8% | — | — | — | — | +12.1% |
| EPS Growth (YoY)Latest quarter vs prior year | +91.1% | +115.0% | +16.0% | +18.3% | +6.8% | +18.2% |
Valuation Metrics
NECB leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 8.0x trailing earnings, NECB trades at a 71% valuation discount to KO's 27.2x P/E. Adjusting for growth (PEG ratio), NECB offers better value at 0.24x vs KO's 2.43x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||||
|---|---|---|---|---|---|---|
| Market CapShares × price | $14M | $89M | $896.0B | $422.8B | $359M | $355.6B |
| Enterprise ValueMkt cap + debt − cash | $19M | $142M | $1.50T | $556.8B | $353M | $390.8B |
| Trailing P/EPrice ÷ TTM EPS | -0.24x | 19.38x | 16.00x | 14.66x | 7.99x | 27.18x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 14.40x | 12.56x | 8.30x | 25.27x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 0.90x | 0.95x | 0.24x | 2.43x |
| EV / EBITDAEnterprise value multiple | — | 21.69x | 18.36x | 13.92x | 5.57x | 26.39x |
| Price / SalesMarket cap ÷ Revenue | 62.34x | 1.84x | 3.20x | 2.21x | 2.28x | 7.42x |
| Price / BookPrice ÷ Book value/share | 0.15x | 1.02x | 2.47x | 1.39x | 1.01x | 10.40x |
| Price / FCFMarket cap ÷ FCF | — | 13.65x | 8.88x | 33.52x | 7.07x | 67.15x |
Profitability & Efficiency
KO leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
KO delivers a 41.1% return on equity — every $100 of shareholder capital generates $41 in annual profit, vs $-60 for CYN. CYN carries lower financial leverage with a 0.18x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), IROQ scores 7/9 vs CYN's 3/9, reflecting strong financial health.
| Metric | ||||||
|---|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -59.6% | +6.2% | +15.9% | +10.1% | +13.1% | +41.1% |
| ROA (TTM)Return on assets | -48.1% | +0.6% | +1.3% | +0.9% | +2.2% | +13.1% |
| ROICReturn on invested capital | -117.2% | +2.9% | +4.5% | +3.5% | +12.5% | +15.8% |
| ROCEReturn on capital employed | -71.5% | +3.9% | +8.9% | +4.5% | +16.2% | +17.3% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 7 | 5 | 7 | 5 | 7 |
| Debt / EquityFinancial leverage | 0.18x | 0.89x | 2.60x | 1.21x | 0.21x | 1.33x |
| Net DebtTotal debt minus cash | $6M | $53M | $599.0B | $134.1B | -$6M | $35.2B |
| Cash & Equiv.Liquid assets | $990,023 | $20M | $343.3B | $231.8B | $81M | $10.3B |
| Total DebtShort + long-term debt | $7M | $73M | $942.4B | $365.9B | $75M | $45.5B |
| Interest CoverageEBIT ÷ Interest expense | -59.79x | 2.72x | 0.74x | 0.48x | 1.17x | 10.70x |
Total Returns (Dividends Reinvested)
Evenly matched — JPM and NECB each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NECB five years ago would be worth $24,194 today (with dividends reinvested), compared to $0 for CYN. Over the past 12 months, BAC leads with a +28.1% total return vs CYN's -72.6%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.6% vs CYN's -95.5% — a key indicator of consistent wealth creation.
| Metric | ||||||
|---|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -54.9% | -1.6% | -0.5% | +1.1% | +15.9% | +20.3% |
| 1-Year ReturnPast 12 months | -72.6% | +11.1% | +21.8% | +28.1% | +17.5% | +17.2% |
| 3-Year ReturnCumulative with dividends | -100.0% | +99.9% | +138.2% | +103.0% | +98.4% | +47.0% |
| 5-Year ReturnCumulative with dividends | -100.0% | +25.4% | +118.2% | +47.1% | +141.9% | +65.6% |
| 10-Year ReturnCumulative with dividends | -100.0% | +60.1% | +465.8% | +368.2% | +500.4% | +121.1% |
| CAGR (3Y)Annualised 3-year return | -95.5% | +26.0% | +33.6% | +26.6% | +25.6% | +13.7% |
Risk & Volatility
Evenly matched — NECB and KO each lead in 1 of 2 comparable metrics.
Risk & Volatility
KO is the less volatile stock with a -0.20 beta — it tends to amplify market swings less than CYN's 2.18 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NECB currently trades 99.8% from its 52-week high vs CYN's 3.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||||
|---|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.18x | -0.05x | 0.94x | 0.86x | 0.71x | -0.20x |
| 52-Week HighHighest price in past year | $41.54 | $29.00 | $337.25 | $57.55 | $26.02 | $84.04 |
| 52-Week LowLowest price in past year | $1.22 | $23.21 | $262.71 | $43.66 | $19.27 | $65.35 |
| % of 52W HighCurrent price vs 52-week peak | +3.0% | +91.6% | +95.1% | +97.3% | +99.8% | +98.3% |
| RSI (14)Momentum oscillator 0–100 | 36.0 | 34.4 | 59.1 | 68.3 | 67.0 | 60.6 |
| Avg Volume (50D)Average daily shares traded | 277K | 103K | 7.0M | 31.7M | 33K | 12.7M |
Analyst Outlook
Evenly matched — NECB and KO each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: JPM as "Buy", BAC as "Buy", NECB as "Hold", KO as "Buy". Consensus price targets imply 9.1% upside for BAC (target: $61) vs 4.2% for KO (target: $86). For income investors, NECB offers the higher dividend yield at 3.75% vs IROQ's 1.54%.
| Metric | ||||||
|---|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | — | — | $339.75 | $61.13 | — | $86.13 |
| # AnalystsCovering analysts | — | — | 61 | 54 | 1 | 48 |
| Dividend YieldAnnual dividend ÷ price | — | +1.5% | +1.9% | +2.3% | +3.8% | +2.5% |
| Dividend StreakConsecutive years of raises | 2 | 0 | 15 | 12 | 2 | 56 |
| Dividend / ShareAnnual DPS | — | $0.41 | $5.95 | $1.27 | $0.98 | $2.04 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +3.9% | +5.1% | +0.4% | +0.2% |
NECB leads in 2 of 6 categories (Income & Cash Flow, Valuation Metrics). KO leads in 1 (Profitability & Efficiency). 3 tied.
CYN vs IROQ vs JPM vs BAC vs NECB vs KO: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CYN or IROQ or JPM or BAC or NECB or KO a better buy right now?
For growth investors, IF Bancorp, Inc.
(IROQ) is the stronger pick with 6. 6% revenue growth year-over-year, versus -40. 5% for Cyngn Inc. (CYN). Northeast Community Bancorp, Inc. (NECB) offers the better valuation at 8. 0x trailing P/E (8. 3x forward), making it the more compelling value choice. Analysts rate JPMorgan Chase & Co. (JPM) a "Buy" — based on 61 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CYN or IROQ or JPM or BAC or NECB or KO?
On trailing P/E, Northeast Community Bancorp, Inc.
(NECB) is the cheapest at 8. 0x versus The Coca-Cola Company at 27. 2x. On forward P/E, Northeast Community Bancorp, Inc. is actually cheaper at 8. 3x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Northeast Community Bancorp, Inc. wins at 0. 25x versus The Coca-Cola Company's 2. 26x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — CYN or IROQ or JPM or BAC or NECB or KO?
Over the past 5 years, Northeast Community Bancorp, Inc.
(NECB) delivered a total return of +141. 9%, compared to -100. 0% for Cyngn Inc. (CYN). Over 10 years, the gap is even starker: NECB returned +500. 4% versus CYN's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CYN or IROQ or JPM or BAC or NECB or KO?
By beta (market sensitivity over 5 years), The Coca-Cola Company (KO) is the lower-risk stock at -0.
20β versus Cyngn Inc. 's 2. 18β — meaning CYN is approximately -1189% more volatile than KO relative to the S&P 500. On balance sheet safety, Cyngn Inc. (CYN) carries a lower debt/equity ratio of 18% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — CYN or IROQ or JPM or BAC or NECB or KO?
By revenue growth (latest reported year), IF Bancorp, Inc.
(IROQ) is pulling ahead at 6. 6% versus -40. 5% for Cyngn Inc. (CYN). On earnings-per-share growth, the picture is similar: IF Bancorp, Inc. grew EPS 140. 4% year-over-year, compared to -7. 7% for Northeast Community Bancorp, Inc.. Over a 3-year CAGR, KO leads at 3. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CYN or IROQ or JPM or BAC or NECB or KO?
Northeast Community Bancorp, Inc.
(NECB) is the more profitable company, earning 28. 2% net margin versus -107. 2% for Cyngn Inc. — meaning it keeps 28. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NECB leads at 39. 6% versus -117. 3% for CYN. At the gross margin level — before operating expenses — NECB leads at 66. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CYN or IROQ or JPM or BAC or NECB or KO more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Northeast Community Bancorp, Inc. (NECB) is the more undervalued stock at a PEG of 0. 25x versus The Coca-Cola Company's 2. 26x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Northeast Community Bancorp, Inc. (NECB) trades at 8. 3x forward P/E versus 25. 3x for The Coca-Cola Company — 17. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BAC: 9. 1% to $61. 13.
08Which pays a better dividend — CYN or IROQ or JPM or BAC or NECB or KO?
In this comparison, NECB (3.
8% yield), KO (2. 5% yield), BAC (2. 3% yield), JPM (1. 9% yield), IROQ (1. 5% yield) pay a dividend. CYN does not pay a meaningful dividend and should not be held primarily for income.
09Is CYN or IROQ or JPM or BAC or NECB or KO better for a retirement portfolio?
For long-horizon retirement investors, The Coca-Cola Company (KO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
20), 2. 5% yield, +121. 1% 10Y return). Cyngn Inc. (CYN) carries a higher beta of 2. 18 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (KO: +121. 1%, CYN: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CYN and IROQ and JPM and BAC and NECB and KO?
These companies operate in different sectors (CYN (Technology) and IROQ (Financial Services) and JPM (Financial Services) and BAC (Financial Services) and NECB (Financial Services) and KO (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CYN is a small-cap quality compounder stock; IROQ is a small-cap quality compounder stock; JPM is a large-cap deep-value stock; BAC is a large-cap deep-value stock; NECB is a small-cap deep-value stock; KO is a large-cap quality compounder stock. IROQ, JPM, BAC, NECB, KO pay a dividend while CYN does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.